menu
    • menu

    Company profile for Oyster Point Pharma

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Oyster Point is a clinical stage pharmaceutical company leveraging neuroscience to discover, develop and commercialize novel therapies to treat diseases with high unmet needs. The company’s initial focus is to develop innovative therapeutics to treat the signs and symptoms of Dry Eye Disease (DED) by stimulating the Trigeminal Parasympathetic Pathway (TPP) to activate the glands responsible for tear film production. The para...
    Oyster Point is a clinical stage pharmaceutical company leveraging neuroscience to discover, develop and commercialize novel therapies to treat diseases with high unmet needs. The company’s initial focus is to develop innovative therapeutics to treat the signs and symptoms of Dry Eye Disease (DED) by stimulating the Trigeminal Parasympathetic Pathway (TPP) to activate the glands responsible for tear film production. The parasympathetic nervous system (PNS) is part of the involuntary nervous system responsible for regulating homeostasis, the “rest and digest” system, and is an important pathway for basal tear film production.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Oyster Point PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    700 Alexander Park Drive, Suite 301 Princeton, New Jersey 08540
    Telephone
    Telephone
    (609) 382-9032
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://oysterpointrx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/oysterpointrx
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/OysterPointRx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences
    Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences

    03 Jan 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/viatris-closes-acquisitions-of-oyster-point-pharma-and-famy-life-sciences-establishing-new-viatris-eye-care-division-301712041.html

    PR NEWSWIRE
    03 Jan 2023
    Share Share
    Oyster Point Pharma Reports Inducement Grants Under Nasdaq Listing
    Oyster Point Pharma Reports Inducement Grants Under Nasdaq Listing

    02 Dec 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2022/12/02/2566670/0/en/Oyster-Point-Pharma-Inc-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    02 Dec 2022
    Share Share
    Viatris jumps into ophthalmology arena with pair of buyouts worth up to $750M
    Viatris jumps into ophthalmology arena with pair of buyouts worth up to $750M

    08 Nov 2022

    // FIERCEPHARMA

    https://www.fiercepharma.com/pharma/viatris-jumps-ophthalmology-ring-oyster-point-pharma-and-fany-life-sciences-purchase-700-750

    FIERCEPHARMA
    08 Nov 2022
    Share Share
    Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company
    Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company

    07 Nov 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/11/07/2549667/0/en/Oyster-Point-Pharma-a-Leading-Ophthalmology-Focused-Biopharmaceutical-Company-to-be-Acquired-by-Viatris.html

    GLOBENEWSWIRE
    07 Nov 2022
    Share Share
    Oyster Point Pharma, Reports Inducement Grants Under Nasdaq Listing
    Oyster Point Pharma, Reports Inducement Grants Under Nasdaq Listing

    04 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/04/2527732/0/en/Oyster-Point-Pharma-Inc-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    04 Oct 2022
    Share Share
    Oyster Point Pharma to Present New Scientific Analyses at World Cornea
    Oyster Point Pharma to Present New Scientific Analyses at World Cornea

    27 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/27/2523268/0/en/Oyster-Point-Pharma-to-Present-New-Scientific-Analyses-at-World-Cornea-Congress-VIII.html

    GLOBENEWSWIRE
    27 Sep 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search